HeartSciences (HSCSW) Debt to Equity (2022 - 2026)

HeartSciences (HSCSW) has 4 years of Debt to Equity data on file, last reported at $0.16 in Q1 2026.

• For the quarter ending Q1 2026, Debt to Equity changed N/A year-over-year to $0.16; the trailing twelve-month figure through Jan 2026 stood at $0.16 (changed N/A YoY), and the FY2023 full-year result was $2.17, up 395.67% from the prior year.
• Debt to Equity for Q1 2026 stood at $0.16, up from $0.01 in the prior quarter.
• Across five years, Debt to Equity topped out at $2.17 in Q2 2023 and bottomed at -$3.88 in Q1 2023.
• The 4-year median for Debt to Equity is $0.05 (2024), against an average of -$0.35.
• Peak annual rise in Debt to Equity reached 395.67% in 2023, while the deepest fall reached 377.78% in 2023.
• A 4-year view of Debt to Equity shows it stood at $0.35 in 2022, then slumped by 377.78% to -$0.96 in 2023, then soared by 101.28% to $0.01 in 2024, then jumped by 1190.62% to $0.16 in 2026.
• The last three Debt to Equity figures came in at $0.16 (Q1 2026), $0.01 (Q4 2024), and $0.08 (Q3 2024), per Business Quant data.

Peer Comparison